首页 | 官方网站   微博 | 高级检索  
     

苯妥英钠代谢酶CYP2C9、CYP2C19基因多态性的分析
引用本文:肖昌琼,张永东,吴志坚,陈尧,张伟,陈锐.苯妥英钠代谢酶CYP2C9、CYP2C19基因多态性的分析[J].郴州医学高等专科学校学报,2013(3):6-9.
作者姓名:肖昌琼  张永东  吴志坚  陈尧  张伟  陈锐
作者单位:[1]郴州市第一人民医院药物临床试验机构,湖南郴州423000 [2]中南大学临床药理研究所,湖南长沙410078 [3]郴州市第一人民医院康复科,湖南郴州423000
基金项目:郴州市第一人民医院院级科研课题(N2011-009)
摘    要:目的研究药物代谢酶基因多态性对苯妥英钠代谢的影响,并建立分析苯妥英钠代谢酶中CYP2C9、CYP2C19基因多态性的方法。方法从人全血中抽取DNA,设计引物扩增CYP2C9及CYP2C19,并运用限制性片段长度多态性(RFLP)技术的方法进行CYP2C9及CYP2C19的基因分型。结果成功设计了引物用来扩增CYP2C9及CYP2C19的基因片段,并测序验证。结论建立了简单可靠的CYP2C9及CYP2C19的RFLP基因分型方法。

关 键 词:苯妥英钠  药物代谢酶  基因多态性

Analysis of CYP2C9 and CYP2C19 gene polymorphism on the metabolic enzyme of Phenytoin Sodium
Affiliation:XIAO Changqiong, ZHANG Yongdong, WU Zhijian, et al I Drug Clinical Trial Institute, The First People's Hospital of Chenzhou, Chenzhou, Hunan 423000, China)
Abstract:Objective To study the effect of drug- metabolizing enzymes polymorphism on the metabolism of Phenytoin Sodium and to set up methods to analyse the CYP2C9 and CYP2C19 gene polymorphism. Methods The DNA were extracted from huxnan blood and PCR was used to amplify the CYP2C9 and CYP2C19 gene. Then restriction fragment length polymorphism(RFLP) was used to classify the CYP2C9 * 3 ,CYP2C19 * 2 and CYP2C19 * 3 genotypes. Results A successful design of the primers was used to contain expansion of CYP2C9 * 3, CYP2C19 * 2 and CYP2C19 * 3 and sequencing and verification were performed. Conclusion A simple and reliable PCR- RFLP method to group the CYV2C9 and CYP2C19 genotypes was established.
Keywords:Phenytoin Sodium  Drug- metabolizing enzymes  Gene polymorphism
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号